431 related articles for article (PubMed ID: 33859636)
1. Role of the IL23/IL17 Pathway in Crohn's Disease.
Schmitt H; Neurath MF; Atreya R
Front Immunol; 2021; 12():622934. PubMed ID: 33859636
[TBL] [Abstract][Full Text] [Related]
2. IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease.
Kobayashi T; Okamoto S; Hisamatsu T; Kamada N; Chinen H; Saito R; Kitazume MT; Nakazawa A; Sugita A; Koganei K; Isobe K; Hibi T
Gut; 2008 Dec; 57(12):1682-9. PubMed ID: 18653729
[TBL] [Abstract][Full Text] [Related]
3. An RORγt Oral Inhibitor Modulates IL-17 Responses in Peripheral Blood and Intestinal Mucosa of Crohn's Disease Patients.
Bassolas-Molina H; Raymond E; Labadia M; Wahle J; Ferrer-Picón E; Panzenbeck M; Zheng J; Harcken C; Hughes R; Turner M; Smith D; Calderón-Gómez E; Esteller M; Carrasco A; Esteve M; Dotti I; Corraliza AM; Masamunt MC; Arajol C; Guardiola J; Ricart E; Nabozny G; Salas A
Front Immunol; 2018; 9():2307. PubMed ID: 30405600
[No Abstract] [Full Text] [Related]
4. Major Role of the IL17/23 Axis in Psoriasis Supports the Development of New Targeted Therapies.
Bugaut H; Aractingi S
Front Immunol; 2021; 12():621956. PubMed ID: 33717124
[TBL] [Abstract][Full Text] [Related]
5. The IL23-IL17 Immune Axis in the Treatment of Ulcerative Colitis: Successes, Defeats, and Ongoing Challenges.
Noviello D; Mager R; Roda G; Borroni RG; Fiorino G; Vetrano S
Front Immunol; 2021; 12():611256. PubMed ID: 34079536
[TBL] [Abstract][Full Text] [Related]
6. Expansion of IL-23 receptor bearing TNFR2+ T cells is associated with molecular resistance to anti-TNF therapy in Crohn's disease.
Schmitt H; Billmeier U; Dieterich W; Rath T; Sonnewald S; Reid S; Hirschmann S; Hildner K; Waldner MJ; Mudter J; Hartmann A; Grützmann R; Neufert C; Münster T; Neurath MF; Atreya R
Gut; 2019 May; 68(5):814-828. PubMed ID: 29848778
[TBL] [Abstract][Full Text] [Related]
7. Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease.
Li J; Ueno A; Fort Gasia M; Luider J; Wang T; Hirota C; Jijon HB; Deane M; Tom M; Chan R; Barkema HW; Beck PL; Kaplan GG; Panaccione R; Qian J; Iacucci M; Gui X; Ghosh S
Inflamm Bowel Dis; 2016 Aug; 22(8):1779-92. PubMed ID: 27243594
[TBL] [Abstract][Full Text] [Related]
8. Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease.
Brand S
Gut; 2009 Aug; 58(8):1152-67. PubMed ID: 19592695
[TBL] [Abstract][Full Text] [Related]
9. Resolution of Crohn's disease.
Schmitt H; Neufert C; Neurath MF; Atreya R
Semin Immunopathol; 2019 Nov; 41(6):737-746. PubMed ID: 31552470
[TBL] [Abstract][Full Text] [Related]
10. Role of the IL-23/IL-17 axis in Crohn's disease.
Siakavellas SI; Bamias G
Discov Med; 2012 Oct; 14(77):253-62. PubMed ID: 23114581
[TBL] [Abstract][Full Text] [Related]
11. Pharmacodynamic mechanisms behind a refractory state in inflammatory bowel disease.
Goll R; Moe ØK; Johnsen KM; Meyer R; Friestad J; Gundersen MD; Kileng H; Johnsen K; Florholmen JR
BMC Gastroenterol; 2022 Nov; 22(1):464. PubMed ID: 36384462
[TBL] [Abstract][Full Text] [Related]
12. TL1A produced by lamina propria macrophages induces Th1 and Th17 immune responses in cooperation with IL-23 in patients with Crohn's disease.
Kamada N; Hisamatsu T; Honda H; Kobayashi T; Chinen H; Takayama T; Kitazume MT; Okamoto S; Koganei K; Sugita A; Kanai T; Hibi T
Inflamm Bowel Dis; 2010 Apr; 16(4):568-75. PubMed ID: 19834969
[TBL] [Abstract][Full Text] [Related]
13. Differential Pathogenic Th17 Profile in Mesenteric Lymph Nodes of Crohn's Disease and Ulcerative Colitis Patients.
Bsat M; Chapuy L; Rubio M; Wassef R; Richard C; Schwenter F; Loungnarath R; Soucy G; Mehta H; Sarfati M
Front Immunol; 2019; 10():1177. PubMed ID: 31191543
[TBL] [Abstract][Full Text] [Related]
14. Importance of TLR9-IL23-IL17 axis in inflammatory bowel disease development: Gene expression profiling study.
Dragasevic S; Stankovic B; Sokic-Milutinovic A; Milosavljevic T; Milovanovic T; Lukic S; Drazilov SS; Klaassen K; Kotur N; Pavlovic S; Popovic D
Clin Immunol; 2018 Dec; 197():86-95. PubMed ID: 30193869
[TBL] [Abstract][Full Text] [Related]
15. [IL-17 and IL23 expression as a predictor of response to infliximab treatment in Crohn's disease].
Zhang X; Hu J; Suo L; Yang Z; Xu T; Zhang Y
Zhonghua Nei Ke Za Zhi; 2015 Nov; 54(11):940-4. PubMed ID: 26922821
[TBL] [Abstract][Full Text] [Related]
16. Reduction of CD68+ macrophages and decreased IL-17 expression in intestinal mucosa of patients with inflammatory bowel disease strongly correlate with endoscopic response and mucosal healing following infliximab therapy.
Caprioli F; Bosè F; Rossi RL; Petti L; Viganò C; Ciafardini C; Raeli L; Basilisco G; Ferrero S; Pagani M; Conte D; Altomare G; Monteleone G; Abrignani S; Reali E
Inflamm Bowel Dis; 2013; 19(4):729-39. PubMed ID: 23448791
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of interleukin-17, interleukin-23 and the TH17 cell pathway in the treatment of psoriatic arthritis and psoriasis.
Mease PJ
Curr Opin Rheumatol; 2015 Mar; 27(2):127-33. PubMed ID: 25599143
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 12/interleukin 23 pathway: Biological basis and therapeutic effect in patients with Crohn's disease.
Aggeletopoulou I; Assimakopoulos SF; Konstantakis C; Triantos C
World J Gastroenterol; 2018 Sep; 24(36):4093-4103. PubMed ID: 30271076
[TBL] [Abstract][Full Text] [Related]
19. Characterization of Th17 tissue-resident memory cells in non-inflamed intestinal tissue of Crohn's disease patients.
Lee Y; Baek J; Park S; Kim Y; Hwang SW; Lee JL; Park SH; Kim J; Yang SK; Han B; Kweon MN; Song K; Yoon YS; Ye BD; Lee HS
J Autoimmun; 2024 May; 145():103206. PubMed ID: 38554656
[TBL] [Abstract][Full Text] [Related]
20. Cross-talk between RORγt+ innate lymphoid cells and intestinal macrophages induces mucosal IL-22 production in Crohn's disease.
Mizuno S; Mikami Y; Kamada N; Handa T; Hayashi A; Sato T; Matsuoka K; Matano M; Ohta Y; Sugita A; Koganei K; Sahara R; Takazoe M; Hisamatsu T; Kanai T
Inflamm Bowel Dis; 2014 Aug; 20(8):1426-34. PubMed ID: 24991784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]